Immulite Rubella Quantitative IgG, Catalog # LKRBQ1 (100 Tests), LKRBQ5 (500 Tests)
510(k) K982078
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK982078 | Date11 Dec 1998 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LFX
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.3510
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Immulite Rubella Quantitative IgG is an enzyme-linked immunoabsorbent assay (ELISA) designed for the quantitative measurement of IgG antibodies to rubella virus in human serum. It functions as a solid-phase chemiluminescent immunoassay, providing objective detection of rubella immunity. This device aids in assessing immune status, particularly for women of childbearing age, to determine susceptibility to rubella infection. The assay is intended for in vitro diagnostic use on the Immulite Automated Analyzer.
This assay is supplied as a single-use reagent kit for laboratory use, requiring no additional sterilization. It is classified under product code LFX and falls under FDA 510(k) clearance (K982078) as a Class II device under special controls for microbiology applications. The kits (LKRBQ1 for 100 tests, LKRBQ5 for 500 tests) are intended for use in clinical microbiology settings. Storage and handling must comply with standard in vitro diagnostic device protocols.
Other devices from Diagnostic Products Corp.
Questions
AI-generated answers, 1 Oct 2026
What is the Immulite Rubella Quantitative IgG kit used for?
This kit uses a solid-phase chemiluminescent immunoassay to measure IgG antibodies against the rubella virus in human serum. It helps determine whether a patient has immunity to rubella, particularly important for women of childbearing age to assess susceptibility to infection during pregnancy. The results provide objective data to guide clinical decisions about vaccination or infection risk.
How is the Immulite Rubella IgG kit supplied, and is it single-use?
The kit is supplied as a single-use reagent kit, available in two configurations: LKRBQ1 for 100 tests and LKRBQ5 for 500 tests. Since it is designed for in vitro diagnostic use on the Immulite Automated Analyzer, each kit is intended for one-time use per its labeled capacity. No additional sterilization is required, as the kit is pre-packaged for laboratory use.
What storage and handling requirements apply to the Immulite Rubella IgG kit?
The kit must be stored and handled according to standard protocols for in vitro diagnostic devices. While specific storage conditions (e.g., temperature) are not detailed here, it is critical to follow the manufacturer’s instructions included with the kit to maintain reagent integrity. Improper storage could compromise assay accuracy, so adherence to recommended guidelines is essential for reliable results.
Are there different sizes or models available for the Immulite Rubella IgG kit?
Yes, the kit is available in two distinct sizes: LKRBQ1 for 100 tests and LKRBQ5 for 500 tests. The choice between models depends on laboratory volume and testing needs. Both versions are compatible with the Immulite Automated Analyzer and share the same assay methodology, ensuring consistency across different kit sizes.
What regulatory pathway does the Immulite Rubella IgG kit follow?
The kit is classified as a Class II medical device under FDA 510(k) clearance (K982078) and falls under product code LFX for microbiology applications. It was determined to be substantially equivalent to a predicate device through a traditional review process by the FDA’s Microbiology (MI) Advisory Committee. This classification reflects its use in clinical microbiology settings for diagnostic purposes.